Propanc Biopharma, Inc. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Propanc Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q3 2024.
  • Propanc Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 688M shares, a 4538% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 688M +673M +4538% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 479M +473M +7839% Jun 30, 2024 10-Q 2024-11-14
Q1 2024 110M -2.51B -95.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 36.2M -1.21B -97.1% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 14.8M -662M -97.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 6.03M +5.81M +2637% Jun 30, 2023 10-K 2024-09-30
Q1 2023 2.62B +2.54B +2983% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1.25B +1.19B +2248% Dec 31, 2022 10-Q 2023-02-10
Q3 2022 677M +633M +1445% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 220K -13.8M -98.4% Jun 30, 2022 10-K 2023-09-28
Q1 2022 85M +80.1M +1611% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 53.1M +51.6M +3567% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 43.8M -672M -93.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 14.1M +13.8M +5345% Jun 30, 2021 10-K 2022-09-28
Q1 2021 4.97M -13.5M -73.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 1.45M -788K -35.3% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 716M +714M +61063% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 258K -710K -73.3% Jun 30, 2020 10-K 2021-09-28
Q1 2020 18.5M -367M -95.2% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 2.23M -271M -99.2% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 1.17M -174M -99.3% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 968K +875K Jun 30, 2019 10-K 2020-10-01
Q1 2019 385M +354M +1139% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 273M +256M +1445% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 176M +169M +2531% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 92.9K* -4.49M Jun 30, 2018 10-K 2019-10-15
Q1 2018 31.1M +27.3M +730% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 17.7M -850M -98% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 6.67M -787M -99.2% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 4.58M +1.66M +57.1% Jun 30, 2017 10-K 2018-09-17
Q1 2017 3.74M -599M -99.4% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 867M +435M +100% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 794M +437M +123% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 2.91M -345M -99.2% Jun 30, 2016 10-K 2017-09-28
Q1 2016 602M +270M +81% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 433M +302M +231% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 357M +274M +331% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 347M +275M +378% Jun 30, 2015 10-K 2016-09-28
Q1 2015 333M +260M +358% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 131M +58.1M +79.9% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 82.8M +11M +15.3% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 72.7M +2.05M +2.91% Jun 30, 2014 10-K 2015-09-30
Q1 2014 72.7M +2.05M +2.91% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 72.7M -136K -0.19% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 71.8M -876K -1.21% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 70.6M -2.07M -2.85% Jun 30, 2013 10-K 2014-10-14
Q1 2013 70.6M -1.52M -2.11% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 72.8M +817K +1.14% Dec 31, 2012 10-Q 2013-02-20
Q3 2012 72.7M Sep 30, 2012 10-Q 2012-11-19
Q2 2012 72.7M +790K +1.1% Jun 30, 2012 10-K 2013-10-15
Q1 2012 72.2M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 72M Dec 31, 2011 10-Q/A 2012-03-07
Q2 2011 71.9M Jun 30, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.